Banque Transatlantique’s MetLife MET Stock Holding History

Banque Transatlantique’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Sell	4,012 -23	-0.6%	-$1.85K	0.01%	259
2026 Q1	$285K	Buy	+4,035	New	+$302K	0.01%	232

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Banque Transatlantique's MET Position: Q2 2026 in Review

Banque Transatlantique reduced its MetLife (MET) stake by 0.57% in Q2 2026, selling an estimated $1.85K and leaving 4,012 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #259.

Banque Transatlantique first reported a position in MET in Q1 2026 and has held it in 2 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Banque Transatlantique held 4,012 shares of MetLife worth $339K as of Q2 2026.
Banque Transatlantique sold 23 MetLife shares in Q2 2026, an estimated $1.85K.
MetLife made up 0.01% of Banque Transatlantique's portfolio in Q2 2026, its #259 holding.
Banque Transatlantique first reported a position in MetLife in Q1 2026 and has held it in 2 quarters since.
1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.